Loading clinical trials...
Loading clinical trials...
A Multi-centre 3-year Follow-up Study to Assess the Viral Activity in Patients Who Failed to Achieve Sustained Virologic Response in Novartis-sponsored Alisporivir-studies for Chronic Hepatitis C Patients
Conditions
Interventions
Previous treatment in DEB025 study
Locations
40
United States
Novartis Investigative Site
San Diego, California, United States
Novartis Investigative Site
Ventura, California, United States
Novartis Investigative Site
Honolulu, Hawaii, United States
Novartis Investigative Site
Springfield, Illinois, United States
Novartis Investigative Site
Arlington, Texas, United States
Novartis Investigative Site
Houston, Texas, United States
Start Date
September 6, 2012
Primary Completion Date
January 23, 2014
Completion Date
January 23, 2014
Last Updated
January 12, 2018
NCT05870969
NCT03200379
NCT03155906
NCT03987503
NCT05397067
NCT04382404
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions